In accordance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, the National Institute of Environmental Health Sciences (NIEHS) has established an Institutional Biosafety Committee (IBC). The IBC is responsible for reviewing projects that involve, but are not limited to, recombinant DNA, RNAi, pathogens, human materials and other potentially infectious material, as well as transgenic animals. The IBC provides recommendations to the intramural community in matters pertaining to the control of biohazards associated with the use of microbiological agents and their vectors. It also represents the interests of the surrounding community with respect to public health and protection of the environment.

Membership Roster

CMDR John McLamb, IBC Contact, Executive SecretaryOM / HSB
David Chen, Ph.D.DIR / VVC
Diane D’Agostin, M.S.DIR / STL
Francesco J. Demayo, Ph.D., IBC Chair, Deputy Chief, RDBLDIR / RDBL
Jacqueline Hamilton, M.A., BCBACommunity Member
Justin Kosak, M.S.DIR / ESCBL
David M. Kurtz, D.V.M., Ph.D.DIR / CMB
Chris McGee, Biologist, Clinical Research UnitDIR / CRB
John McLamb, CHP, RRPT, Radiation Safety OfficerOM / HSB
Steve Novak, CSP, Deputy Chief, HSBOM / HSB
Robert Petrovich, Ph.D., Protein Expression CoreDIR / GISBL
Janine Santos, Group Leader, MTB, DTTNTP / SCT
Troy WeaverCommunity Member

IBC Calendar

Please make note of the 2024 Institutional Biosafety Committee (IBC) Calendar.

The IBC meets once every month, on the 2nd Thursday of each month. Submissions must be received by close of business (5:00 p.m.) at least 10 days prior for consideration at the IBC monthly meeting. You will find a below guide on submitting your biological material registrations through EHSA.

If you have any additional questions, please feel free to reach out to the HSB Biosafety Specialist at 984-287-3400.

MonthSubmission DeadlineMeeting Date
JanuaryJanuary 1January 11
FebruaryJanuary 29February 8
MarchMarch 4March 14
AprilApril 1April 11
MayApril 30May 9
JuneJune 3June 13
JulyJune 1July 11
AugustJuly 29August 8
SeptemberSeptember 2September 12
OctoberSeptember 30October 10
NovemberNovember 4November 14
DecemberDecember 2December 12
  1. Principal Investigators are responsible for ensuring IBC review of the following:
    • Animal experiments requiring IBC approval with any of the above (prior to ACUC approval)
    • Biological Toxins (CDC-USDA agent program toxins below the permissible toxin amount)
    • Human and Non-human Primate (NHP): blood, body fluids, tissues and primary or established cell lines
    • Pathogens/Microorganisms: Risk Group 1 or higher
    • Recombinant or Synthetic DNA work as defined by the NIH Guidelines
  2. Please be reminded that any ACUC Animal Study Protocol (ASP) that includes the use of biologicals agents, toxins, human-derived materials, or recombinant DNA, etc. requires a BIO Permit and must be approved prior to receiving ACUC approval.